Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 33 entries
Sorted by: Best Match Show Resources per page
Improved performance and consistency of deep learning 3D liver segmentation with heterogeneous cancer stages in magnetic resonance imaging.

PloS one

Gross M, Spektor M, Jaffe A, Kucukkaya AS, Iseke S, Haider SP, Strazzabosco M, Chapiro J, Onofrey JA.
PMID: 34852007
PLoS One. 2021 Dec 01;16(12):e0260630. doi: 10.1371/journal.pone.0260630. eCollection 2021.

PURPOSE: Accurate liver segmentation is key for volumetry assessment to guide treatment decisions. Moreover, it is an important pre-processing step for cancer detection algorithms. Liver segmentation can be especially challenging in patients with cancer-related tissue changes and shape deformation....

Cite
Gross M, Spektor M, Jaffe A, et al. Improved performance and consistency of deep learning 3D liver segmentation with heterogeneous cancer stages in magnetic resonance imaging. PLoS One. 2021;16(12):e0260630doi: 10.1371/journal.pone.0260630.
Gross, M., Spektor, M., Jaffe, A., Kucukkaya, A. S., Iseke, S., Haider, S. P., Strazzabosco, M., Chapiro, J., & Onofrey, J. A. (2021). Improved performance and consistency of deep learning 3D liver segmentation with heterogeneous cancer stages in magnetic resonance imaging. PloS one, 16(12), e0260630. https://doi.org/10.1371/journal.pone.0260630
Gross, Moritz, et al. "Improved performance and consistency of deep learning 3D liver segmentation with heterogeneous cancer stages in magnetic resonance imaging." PloS one vol. 16,12 (2021): e0260630. doi: https://doi.org/10.1371/journal.pone.0260630
Gross M, Spektor M, Jaffe A, Kucukkaya AS, Iseke S, Haider SP, Strazzabosco M, Chapiro J, Onofrey JA. Improved performance and consistency of deep learning 3D liver segmentation with heterogeneous cancer stages in magnetic resonance imaging. PLoS One. 2021 Dec 01;16(12):e0260630. doi: 10.1371/journal.pone.0260630. eCollection 2021. PMID: 34852007; PMCID: PMC8635384.
Copy Download .nbib Format: NLM
TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection.

Microorganisms

Bortolotti D, Gentili V, Rizzo S, Schiuma G, Beltrami S, Strazzabosco G, Fernandez M, Caccuri F, Caruso A, Rizzo R.
PMID: 34576716
Microorganisms. 2021 Aug 26;9(9). doi: 10.3390/microorganisms9091820.

(1) Background: Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent for the coronavirus disease (COVID-19) that has led to a pandemic that began in March 2020. The role of the SARS-CoV-2 components on innate and adaptive immunity...

Cite
Bortolotti D, Gentili V, Rizzo S, et al. TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection. Microorganisms. 2021;9(9)doi: 10.3390/microorganisms9091820.
Bortolotti, D., Gentili, V., Rizzo, S., Schiuma, G., Beltrami, S., Strazzabosco, G., Fernandez, M., Caccuri, F., Caruso, A., & Rizzo, R. (2021). TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection. Microorganisms, 9(9), . https://doi.org/10.3390/microorganisms9091820
Bortolotti, Daria, et al. "TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection." Microorganisms vol. 9,9 (2021). doi: https://doi.org/10.3390/microorganisms9091820
Bortolotti D, Gentili V, Rizzo S, Schiuma G, Beltrami S, Strazzabosco G, Fernandez M, Caccuri F, Caruso A, Rizzo R. TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection. Microorganisms. 2021 Aug 26;9(9). doi: 10.3390/microorganisms9091820. PMID: 34576716; PMCID: PMC8465566.
Copy Download .nbib Format: NLM
Fibrocystic liver disease: novel concepts and translational perspectives.

Translational gastroenterology and hepatology

Lasagni A, Cadamuro M, Morana G, Fabris L, Strazzabosco M.
PMID: 33824930
Transl Gastroenterol Hepatol. 2021 Apr 05;6:26. doi: 10.21037/tgh-2020-04. eCollection 2021.

Fibrocystic liver diseases (FLDs) comprise a heterogeneous group of rare diseases of the biliary tree, having in common an abnormal development of the embryonic ductal plate caused by genetically-determined dysfunctions of proteins expressed in the primary cilia of cholangiocytes...

Cite
Lasagni A, Cadamuro M, Morana G, et al. Fibrocystic liver disease: novel concepts and translational perspectives. Transl Gastroenterol Hepatol. 2021;6:26doi: 10.21037/tgh-2020-04.
Lasagni, A., Cadamuro, M., Morana, G., Fabris, L., & Strazzabosco, M. (2021). Fibrocystic liver disease: novel concepts and translational perspectives. Translational gastroenterology and hepatology, 626. https://doi.org/10.21037/tgh-2020-04
Lasagni, Alberto, et al. "Fibrocystic liver disease: novel concepts and translational perspectives." Translational gastroenterology and hepatology vol. 6 (2021): 26. doi: https://doi.org/10.21037/tgh-2020-04
Lasagni A, Cadamuro M, Morana G, Fabris L, Strazzabosco M. Fibrocystic liver disease: novel concepts and translational perspectives. Transl Gastroenterol Hepatol. 2021 Apr 05;6:26. doi: 10.21037/tgh-2020-04. eCollection 2021. PMID: 33824930; PMCID: PMC7838530.
Copy Download .nbib Format: NLM
The balance between Notch/Wnt signaling regulates progenitor cells' commitment during liver repair: mystery solved?.

Journal of hepatology

Strazzabosco M, Fabris L.
PMID: 22902547
J Hepatol. 2013 Jan;58(1):181-3. doi: 10.1016/j.jhep.2012.08.006. Epub 2012 Aug 15.

No abstract available.

Cite
Strazzabosco M, Fabris L. The balance between Notch/Wnt signaling regulates progenitor cells' commitment during liver repair: mystery solved?. J Hepatol. 2012;58(1):181-3doi: 10.1016/j.jhep.2012.08.006.
Strazzabosco, M., & Fabris, L. (2013). The balance between Notch/Wnt signaling regulates progenitor cells' commitment during liver repair: mystery solved?. Journal of hepatology, 58(1), 181-3. https://doi.org/10.1016/j.jhep.2012.08.006
Strazzabosco, Mario, and Fabris, Luca. "The balance between Notch/Wnt signaling regulates progenitor cells' commitment during liver repair: mystery solved?." Journal of hepatology vol. 58,1 (2013): 181-3. doi: https://doi.org/10.1016/j.jhep.2012.08.006
Strazzabosco M, Fabris L. The balance between Notch/Wnt signaling regulates progenitor cells' commitment during liver repair: mystery solved?. J Hepatol. 2013 Jan;58(1):181-3. doi: 10.1016/j.jhep.2012.08.006. Epub 2012 Aug 15. PMID: 22902547.
Copy Download .nbib Format: NLM
Vascular endothelial growth factors in progenitor cells mediated liver repair.

Hepatobiliary surgery and nutrition

Spirli C, Strazzabosco M.
PMID: 24570918
Hepatobiliary Surg Nutr. 2013 Apr;2(2):65-7. doi: 10.3978/j.issn.2304-3881.2012.12.05.

No abstract available.

Cite
Spirli C, Strazzabosco M. Vascular endothelial growth factors in progenitor cells mediated liver repair. Hepatobiliary Surg Nutr. 2013;2(2):65-7doi: 10.3978/j.issn.2304-3881.2012.12.05.
Spirli, C., & Strazzabosco, M. (2013). Vascular endothelial growth factors in progenitor cells mediated liver repair. Hepatobiliary surgery and nutrition, 2(2), 65-7. https://doi.org/10.3978/j.issn.2304-3881.2012.12.05
Spirli, Carlo, and Strazzabosco, Mario. "Vascular endothelial growth factors in progenitor cells mediated liver repair." Hepatobiliary surgery and nutrition vol. 2,2 (2013): 65-7. doi: https://doi.org/10.3978/j.issn.2304-3881.2012.12.05
Spirli C, Strazzabosco M. Vascular endothelial growth factors in progenitor cells mediated liver repair. Hepatobiliary Surg Nutr. 2013 Apr;2(2):65-7. doi: 10.3978/j.issn.2304-3881.2012.12.05. PMID: 24570918; PMCID: PMC3924655.
Copy Download .nbib Format: NLM
The use of isolated rat hepatocyte couplets, microscopic optical planimetry and quantitative microfluorimetry in hepatobiliary physiology.

Cytotechnology

Strazzabosco M, Boyer JL, Crepaldi G.
PMID: 22358966
Cytotechnology. 1991 Feb;5:88-9. doi: 10.1007/BF00736820.

No abstract available.

Cite
Strazzabosco M, Boyer JL, Crepaldi G. The use of isolated rat hepatocyte couplets, microscopic optical planimetry and quantitative microfluorimetry in hepatobiliary physiology. Cytotechnology. 1991;5:88-9doi: 10.1007/BF00736820.
Strazzabosco, M., Boyer, J. L., & Crepaldi, G. (1991). The use of isolated rat hepatocyte couplets, microscopic optical planimetry and quantitative microfluorimetry in hepatobiliary physiology. Cytotechnology, 588-9. https://doi.org/10.1007/BF00736820
Strazzabosco, M, et al. "The use of isolated rat hepatocyte couplets, microscopic optical planimetry and quantitative microfluorimetry in hepatobiliary physiology." Cytotechnology vol. 5 (1991): 88-9. doi: https://doi.org/10.1007/BF00736820
Strazzabosco M, Boyer JL, Crepaldi G. The use of isolated rat hepatocyte couplets, microscopic optical planimetry and quantitative microfluorimetry in hepatobiliary physiology. Cytotechnology. 1991 Feb;5:88-9. doi: 10.1007/BF00736820. PMID: 22358966.
Copy Download .nbib Format: NLM
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?.

Journal of clinical medicine

Brivio S, Cadamuro M, Fabris L, Strazzabosco M.
PMID: 26703747
J Clin Med. 2015 Dec 19;4(12):2028-41. doi: 10.3390/jcm4121958.

In addition to its well-established role in embryo development, epithelial-to-mesenchymal transition (EMT) has been proposed as a general mechanism favoring tumor metastatization in several epithelial malignancies. Herein, we review the topic of EMT in cholangiocarcinoma (CCA), a primary liver...

Cite
Brivio S, Cadamuro M, Fabris L, et al. Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?. J Clin Med. 2015;4(12):2028-41doi: 10.3390/jcm4121958.
Brivio, S., Cadamuro, M., Fabris, L., & Strazzabosco, M. (2015). Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?. Journal of clinical medicine, 4(12), 2028-41. https://doi.org/10.3390/jcm4121958
Brivio, Simone, et al. "Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?." Journal of clinical medicine vol. 4,12 (2015): 2028-41. doi: https://doi.org/10.3390/jcm4121958
Brivio S, Cadamuro M, Fabris L, Strazzabosco M. Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?. J Clin Med. 2015 Dec 19;4(12):2028-41. doi: 10.3390/jcm4121958. PMID: 26703747; PMCID: PMC4693158.
Copy Download .nbib Format: NLM
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness.

World journal of hepatology

Brivio S, Cadamuro M, Strazzabosco M, Fabris L.
PMID: 28396716
World J Hepatol. 2017 Mar 28;9(9):455-468. doi: 10.4254/wjh.v9.i9.455.

Cholangiocarcinoma (CCA) is a highly aggressive epithelial malignancy still carrying a dismal prognosis, owing to early lymph node metastatic dissemination and striking resistance to conventional chemotherapy. Although mechanisms underpinning CCA progression are still a conundrum, it is now increasingly...

Cite
Brivio S, Cadamuro M, Strazzabosco M, et al. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness. World J Hepatol. 2017;9(9):455-468doi: 10.4254/wjh.v9.i9.455.
Brivio, S., Cadamuro, M., Strazzabosco, M., & Fabris, L. (2017). Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness. World journal of hepatology, 9(9), 455-468. https://doi.org/10.4254/wjh.v9.i9.455
Brivio, Simone, et al. "Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness." World journal of hepatology vol. 9,9 (2017): 455-468. doi: https://doi.org/10.4254/wjh.v9.i9.455
Brivio S, Cadamuro M, Strazzabosco M, Fabris L. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness. World J Hepatol. 2017 Mar 28;9(9):455-468. doi: 10.4254/wjh.v9.i9.455. PMID: 28396716; PMCID: PMC5368623.
Copy Download .nbib Format: NLM
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Cortesi PA, Mantovani L, Ciaccio A, Rota M, Cesana G, Strazzabosco M, Belli LS.
PMID: 27200773
Value Health. 2014 Nov;17(7):A367-8. doi: 10.1016/j.jval.2014.08.826. Epub 2014 Oct 26.

No abstract available.

Cite
Cortesi PA, Mantovani L, Ciaccio A, et al. The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation. Value Health. 2014;17(7):A367-8doi: 10.1016/j.jval.2014.08.826.
Cortesi, P. A., Mantovani, L., Ciaccio, A., Rota, M., Cesana, G., Strazzabosco, M., & Belli, L. S. (2014). The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A367-8. https://doi.org/10.1016/j.jval.2014.08.826
Cortesi, P A, et al. "The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A367-8. doi: https://doi.org/10.1016/j.jval.2014.08.826
Cortesi PA, Mantovani L, Ciaccio A, Rota M, Cesana G, Strazzabosco M, Belli LS. The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation. Value Health. 2014 Nov;17(7):A367-8. doi: 10.1016/j.jval.2014.08.826. Epub 2014 Oct 26. PMID: 27200773.
Copy Download .nbib Format: NLM
The Tumor Microenvironment in Cholangiocarcinoma Progression.

Hepatology (Baltimore, Md.)

Fabris L, Sato K, Alpini G, Strazzabosco M.
PMID: 32500550
Hepatology. 2021 Jan;73:75-85. doi: 10.1002/hep.31410. Epub 2020 Nov 06.

No abstract available.

Cite
Fabris L, Sato K, Alpini G, et al. The Tumor Microenvironment in Cholangiocarcinoma Progression. Hepatology. 2020;73:75-85doi: 10.1002/hep.31410.
Fabris, L., Sato, K., Alpini, G., & Strazzabosco, M. (2021). The Tumor Microenvironment in Cholangiocarcinoma Progression. Hepatology (Baltimore, Md.), 7375-85. https://doi.org/10.1002/hep.31410
Fabris, Luca, et al. "The Tumor Microenvironment in Cholangiocarcinoma Progression." Hepatology (Baltimore, Md.) vol. 73 (2021): 75-85. doi: https://doi.org/10.1002/hep.31410
Fabris L, Sato K, Alpini G, Strazzabosco M. The Tumor Microenvironment in Cholangiocarcinoma Progression. Hepatology. 2021 Jan;73:75-85. doi: 10.1002/hep.31410. Epub 2020 Nov 06. PMID: 32500550; PMCID: PMC7714713.
Copy Download .nbib Format: NLM
The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases.

Frontiers in medicine

Cadamuro M, Girardi N, Gores GJ, Strazzabosco M, Fabris L.
PMID: 32373615
Front Med (Lausanne). 2020 Apr 21;7:115. doi: 10.3389/fmed.2020.00115. eCollection 2020.

Cholangiopathies are a heterogeneous group of chronic liver diseases caused by different types of injury targeting the biliary epithelium, such as genetic defects and immune-mediated attacks. Notably, most cholangiopathies are orphan, thereby representing one of the major gaps in...

Cite
Cadamuro M, Girardi N, Gores GJ, et al. The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases. Front Med (Lausanne). 2020;7:115doi: 10.3389/fmed.2020.00115.
Cadamuro, M., Girardi, N., Gores, G. J., Strazzabosco, M., & Fabris, L. (2020). The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases. Frontiers in medicine, 7115. https://doi.org/10.3389/fmed.2020.00115
Cadamuro, Massimiliano, et al. "The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases." Frontiers in medicine vol. 7 (2020): 115. doi: https://doi.org/10.3389/fmed.2020.00115
Cadamuro M, Girardi N, Gores GJ, Strazzabosco M, Fabris L. The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases. Front Med (Lausanne). 2020 Apr 21;7:115. doi: 10.3389/fmed.2020.00115. eCollection 2020. PMID: 32373615; PMCID: PMC7186419.
Copy Download .nbib Format: NLM
The Tumor Microenvironment in Cholangiocarcinoma Progression.

Hepatology (Baltimore, Md.)

Fabris L, Sato K, Alpini G, Strazzabosco M.
PMID: 32500550
Hepatology. 2021 Jan;73:75-85. doi: 10.1002/hep.31410. Epub 2020 Nov 06.

No abstract available.

Cite
Fabris L, Sato K, Alpini G, et al. The Tumor Microenvironment in Cholangiocarcinoma Progression. Hepatology. 2020;73:75-85doi: 10.1002/hep.31410.
Fabris, L., Sato, K., Alpini, G., & Strazzabosco, M. (2021). The Tumor Microenvironment in Cholangiocarcinoma Progression. Hepatology (Baltimore, Md.), 7375-85. https://doi.org/10.1002/hep.31410
Fabris, Luca, et al. "The Tumor Microenvironment in Cholangiocarcinoma Progression." Hepatology (Baltimore, Md.) vol. 73 (2021): 75-85. doi: https://doi.org/10.1002/hep.31410
Fabris L, Sato K, Alpini G, Strazzabosco M. The Tumor Microenvironment in Cholangiocarcinoma Progression. Hepatology. 2021 Jan;73:75-85. doi: 10.1002/hep.31410. Epub 2020 Nov 06. PMID: 32500550; PMCID: PMC7714713.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 33 entries